Vogt-小柳-原田病的分类标准
早期VKH的关键标准包括渗出性视网膜脱离或全葡萄膜炎伴≥2个神经系统症状;晚期VKH需有早期病史并出现晚霞状眼底或葡萄膜炎伴皮肤体征。该标准在验证集中总体准确率为94.0%。
要点
- 早期VKH标准:渗出性视网膜脱离(FFA或OCT特征)或全葡萄膜炎伴≥2个神经系统症状。
- 晚期VKH标准:早期VKH病史加晚霞状眼底或葡萄膜炎伴≥1个皮肤体征。
- 分类标准在验证集中总体准确率94.0%,早期VKH误分类率7.7%。
核心结论
- VKH分类标准误分类率较低,适用于临床和转化研究。
主要发现
- 训练集总体准确率96.3%,验证集94.0%(95%CI 89.0-96.8)。
- 早期VKH误分类率训练集8.0%,验证集7.7%;晚期VKH误分类率训练集1.0%,验证集12%。
关键数值与推荐
- 早期VKH关键标准:渗出性视网膜脱离伴FFA或OCT特征性表现,或全葡萄膜炎伴5个神经系统症状/体征中≥2个。
- 晚期VKH关键标准:早期VKH病史,且晚霞状眼底或葡萄膜炎伴3个皮肤体征中≥1个。
- 验证集总体准确率94.0%(95%CI 89.0-96.8)。
临床怎么用
- 临床可依据上述标准对VKH进行早期和晚期分类,辅助诊断和研究分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine classification criteria for Vogt-Koyanagi-Harada (VKH) disease. DESIGN: Machine learning of cases with VKH disease and 5 other panuveitides. METHODS: Cases of panuveitides were collected in an informatics-designed preliminary database, and a final database was constructed of cases achieving supermajority agreement on the diagnosis, using formal consensus techniques. Cases were split into a training set and a validation set. Machine learning using multinomial logistic regression was used on the training set to determine a parsimonious set of criteria that minimized the misclassification rate among the panuveitides. The resulting criteria were evaluated on the validation set. RESULTS: One thousand twelve cases of panuveitides, including 156 cases of early-stage VKH and 103 cases of late-stage VKH, were evaluated. Overall accuracy for panuveitides was 96.3% in the training set and 94.0% in the validation set (95% confidence interval 89.0, 96.8). Key criteria for early-stage VKH included the following: (1) exudative retinal detachment with characteristic appearance on fluorescein angiogram or optical coherence tomography or (2) panuveitis with ≥2 of 5 neurologic symptoms/signs. Key criteria for late-stage VKH included history of early-stage VKH and either (1) sunset glow fundus or (2) uveitis and ≥1 of 3 cutaneous signs. The misclassification rates in the learning and validation sets for early-stage VKH were 8.0% and 7.7%, respectively, and for late-stage VKH 1.0% and 12%, respectively. CONCLUSIONS: The criteria for VKH had a reasonably low misclassification rate and seemed to perform sufficiently well for use in clinical and translational research.
引用
- Classification Criteria for Vogt-Koyanagi-Harada Disease. Am J Ophthalmol. 2021. PMID: 33845018. doi:10.1016/j.ajo.2021.03.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。